Katherine Forbush
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katherine Forbush has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- John D. Scott
Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington
5 shared publications - Janani Gopalan
Allen Institute for Cell Science Seattle
2 shared publications Jerome Falcone
2 shared publications- Jerome I. Falcone
Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA
2 shared publications John Scott
2 shared publications- Mingu Kang
Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA
2 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (4) , 111329
AKAP2 is required for assembly of cytoskeletal signaling complexes that promote growth and metastasis of triple-negative breast cancer
- 27 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (4) , 111329
Open AccessAKAP2 is required for assembly of cytoskeletal signaling complexes that promote growth and metastasis of triple-negative breast cancer
- Open Access
- 29 May 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110317
Long AKAP18 isoforms anchor ubiquitin specific proteinases and coordinate calcium reuptake at the sarcoplasmic reticulum
- 29 May 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110317
Open AccessLong AKAP18 isoforms anchor ubiquitin specific proteinases and coordinate calcium reuptake at the sarcoplasmic reticulum
- Open Access
- 8 April 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108480
The evolution of AKAPs and emergence of PKA isotype selective anchoring determinants
- 8 April 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108480
Open AccessThe evolution of AKAPs and emergence of PKA isotype selective anchoring determinants
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S776-S777
Abstract 2258: In Situ Targeting of Adrenal Cushing's Syndrome PKAc-L205R Disease Variant
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S776-S777
Open AccessAbstract 2258: In Situ Targeting of Adrenal Cushing's Syndrome PKAc-L205R Disease Variant
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S783
Abstract 2371: Preferential interactions of A-kinase anchoring proteins with different protein kinase A subtypes
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S783
Open AccessAbstract 2371: Preferential interactions of A-kinase anchoring proteins with different protein kinase A subtypes
- Open Access
- 12 July 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Targeting an anchored phosphatase-deacetylase unit restores renal ciliary homeostasis
Pathophysiological defects in water homeostasis can lead to renal failure. Likewise, common genetic disorders associated with abnormal cytoskeletal dynamics in the kidney collecting ducts and perturbed calcium and cAMP signaling in the ciliary compartment contribute to chronic kidney failure. We show that collecting ducts in mice lacking the A-Kinase anchoring protein AKAP220 exhibit enhanced development of primary cilia. Mechanistic studies reveal that AKAP220-associated protein phosphatase 1 (PP1) mediates this phenotype by promoting changes in the stability of histone deacetylase 6 (HDAC6) with concomitant defects in actin dynamics. This proceeds through a previously unrecognized adaptor function for PP1 as all ciliogenesis and cytoskeletal phenotypes are recapitulated in mIMCD3 knock-in cells expressing a phosphatase-targeting defective AKAP220-ΔPP1 mutant. Pharmacological blocking of local HDAC6 activity alters cilia development and reduces cystogenesis in kidney-on-chip and organoid models. These findings identify the AKAP220-PPI-HDAC6 pathway as a key effector in primary cilia development.
- 12 July 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Open AccessTargeting an anchored phosphatase-deacetylase unit restores renal ciliary homeostasis
Pathophysiological defects in water homeostasis can lead to renal failure. Likewise, common genetic disorders associated with abnormal cytoskeletal dynamics in the kidney collecting ducts and perturbed calcium and cAMP signaling in the ciliary compartment contribute to chronic kidney failure. We show that collecting ducts in mice lacking the A-Kinase anchoring protein AKAP220 exhibit enhanced development of primary cilia. Mechanistic studies reveal that AKAP220-associated protein phosphatase 1 (PP1) mediates this phenotype by promoting changes in the stability of histone deacetylase 6 (HDAC6) with concomitant defects in actin dynamics. This proceeds through a previously unrecognized adaptor function for PP1 as all ciliogenesis and cytoskeletal phenotypes are recapitulated in mIMCD3 knock-in cells expressing a phosphatase-targeting defective AKAP220-ΔPP1 mutant. Pharmacological blocking of local HDAC6 activity alters cilia development and reduces cystogenesis in kidney-on-chip and organoid models. These findings identify the AKAP220-PPI-HDAC6 pathway as a key effector in primary cilia development.
- Open Access
- 11 July 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (30) , 201607745-37
AKAP220 manages apical actin networks that coordinate aquaporin-2 location and renal water reabsorption
Filtration through the kidney eliminates toxins, manages electrolyte balance, and controls water homeostasis. Reabsorption of water from the luminal fluid of the nephron occurs through aquaporin-2 (AQP2) water pores in principal cells that line the kidney-collecting duct. This vital process is impeded by formation of an “actin barrier” that obstructs the passive transit of AQP2 to the plasma membrane. Bidirectional control of AQP2 trafficking is managed by hormones and signaling enzymes. We have discovered that vasopressin-independent facets of this homeostatic mechanism are under the control of A-Kinase Anchoring Protein 220 (AKAP220; product of the Akap11 gene). CRISPR/Cas9 gene editing and imaging approaches show that loss of AKAP220 disrupts apical actin networks in organoid cultures. Similar defects are evident in tissue sections from AKAP220-KO mice. Biochemical analysis of AKAP220-null kidney extracts detected reduced levels of active RhoA GTPase, a well-known modulator of the actin cytoskeleton. Fluorescent imaging of kidney sections from these genetically modified mice revealed that RhoA and AQP2 accumulate at the apical surface of the collecting duct. Consequently, these animals are unable to appropriately dilute urine in response to overhydration. We propose that membrane-proximal signaling complexes constrained by AKAP220 impact the actin barrier dynamics and AQP2 trafficking to ensure water homeostasis.
- 11 July 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (30) , 201607745-37
Open AccessAKAP220 manages apical actin networks that coordinate aquaporin-2 location and renal water reabsorption
Filtration through the kidney eliminates toxins, manages electrolyte balance, and controls water homeostasis. Reabsorption of water from the luminal fluid of the nephron occurs through aquaporin-2 (AQP2) water pores in principal cells that line the kidney-collecting duct. This vital process is impeded by formation of an “actin barrier” that obstructs the passive transit of AQP2 to the plasma membrane. Bidirectional control of AQP2 trafficking is managed by hormones and signaling enzymes. We have discovered that vasopressin-independent facets of this homeostatic mechanism are under the control of A-Kinase Anchoring Protein 220 (AKAP220; product of the Akap11 gene). CRISPR/Cas9 gene editing and imaging approaches show that loss of AKAP220 disrupts apical actin networks in organoid cultures. Similar defects are evident in tissue sections from AKAP220-KO mice. Biochemical analysis of AKAP220-null kidney extracts detected reduced levels of active RhoA GTPase, a well-known modulator of the actin cytoskeleton. Fluorescent imaging of kidney sections from these genetically modified mice revealed that RhoA and AQP2 accumulate at the apical surface of the collecting duct. Consequently, these animals are unable to appropriately dilute urine in response to overhydration. We propose that membrane-proximal signaling complexes constrained by AKAP220 impact the actin barrier dynamics and AQP2 trafficking to ensure water homeostasis.